Literature DB >> 15994916

Mammalian sterile 20-like kinases in tumor suppression: an emerging pathway.

Eric E O'Neill1, David Matallanas, Walter Kolch.   

Abstract

Emerging evidence suggests that the proapoptotic kinase mammalian sterile 20-like kinase 2 (MST2) acts in a novel tumor suppression pathway. Recently, we showed that Raf-1 kinase sequesters and inhibits MST2 and that this event is critical for Raf-mediated cell survival. In this review, we summarize Raf control of MST2 and we outline a novel pathway involving the downstream effector proteins Salvador and Warts/Lats that may act to limit the positive effects of Raf-mitogen-activated protein kinase signaling in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994916     DOI: 10.1158/0008-5472.CAN-05-1453

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

2.  Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription.

Authors:  Jens Rauch; Eric O'Neill; Brigitte Mack; Christoph Matthias; Markus Munz; Walter Kolch; Olivier Gires
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

3.  The NDR kinase DBF-2 is involved in regulation of mitosis, conidial development, and glycogen metabolism in Neurospora crassa.

Authors:  Efrat Dvash; Galia Kra-Oz; Carmit Ziv; Shmuel Carmeli; Oded Yarden
Journal:  Eukaryot Cell       Date:  2009-12-04

4.  Structural comparison of human mammalian ste20-like kinases.

Authors:  Christopher J Record; Apirat Chaikuad; Peter Rellos; Sanjan Das; Ashley C W Pike; Oleg Fedorov; Brian D Marsden; Stefan Knapp; Wen Hwa Lee
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

5.  In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors.

Authors:  Natalia Skobeleva; Sanjay Menon; Lutz Weber; Erica A Golemis; Vladimir Khazak
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261

6.  MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival.

Authors:  Capucine Picard; Nizar Mahlaoui; Alain Fischer; Geneviève de Saint Basile; Nadine T Nehme; Jana Pachlopnik Schmid; Franck Debeurme; Isabelle André-Schmutz; Annick Lim; Patrick Nitschke; Frédéric Rieux-Laucat; Patrick Lutz
Journal:  Blood       Date:  2011-12-14       Impact factor: 22.113

7.  Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.

Authors:  Chao-Yuan Huang; Shu-Pin Huang; Victor C Lin; Chia-Cheng Yu; Ta-Yuan Chang; Shin-Hun Juang; Bo-Ying Bao
Journal:  Sci Rep       Date:  2015-02-24       Impact factor: 4.379

8.  Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.

Authors:  Doris M Benbrook; Stan Lightfoot; James Ranger-Moore; Tongzu Liu; Shylet Chengedza; William L Berry; Igor Dozmorov
Journal:  Gene Regul Syst Bio       Date:  2008

9.  RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.

Authors:  David Matallanas; David Romano; Karen Yee; Katrin Meissl; Lucia Kucerova; Daniela Piazzolla; Manuela Baccarini; J Keith Vass; Walter Kolch; Eric O'neill
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

10.  RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?

Authors:  Simon F Scrace; Eric O'Neill
Journal:  Mol Biol Int       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.